These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 15649706

  • 1. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
    Xu L, Sheng J, Tang Z, Wu X, Yu Y, Guo H, Shen Y, Zhou C, Paraoan L, Zhou J.
    Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 3. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ, Batchelor PE, Howells DW.
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [Abstract] [Full Text] [Related]

  • 4. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K, Finkelstein DI, Gundlach AL.
    Brain Res; 2009 May 19; 1271():83-94. PubMed ID: 19328193
    [Abstract] [Full Text] [Related]

  • 5. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ, Rauhala P, Tuominen RK, Liesi P.
    J Neurosci Res; 2006 Aug 15; 84(3):655-65. PubMed ID: 16810683
    [Abstract] [Full Text] [Related]

  • 6. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C, Kirik D, Björklund A.
    Exp Neurol; 2000 Feb 15; 161(2):503-16. PubMed ID: 10686072
    [Abstract] [Full Text] [Related]

  • 7. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G, Silva C, Maximino JR, Fuxe K, da Silva GO.
    Brain Res; 2008 Jan 23; 1190():23-38. PubMed ID: 18086466
    [Abstract] [Full Text] [Related]

  • 8. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
    Ding YM, Jaumotte JD, Signore AP, Zigmond MJ.
    J Neurochem; 2004 May 23; 89(3):776-87. PubMed ID: 15086533
    [Abstract] [Full Text] [Related]

  • 9. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, Tansey KE, Tansey MG.
    J Neurosci; 2006 Sep 13; 26(37):9365-75. PubMed ID: 16971520
    [Abstract] [Full Text] [Related]

  • 10. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ, Bian GL, Bai Y, Cao R, Chen LW.
    Neurochem Int; 2008 Sep 13; 53(3-4):56-62. PubMed ID: 18639597
    [Abstract] [Full Text] [Related]

  • 11. Subthalamic nucleus lesioning inhibits expression and phosphorylation of c-Jun in nigral neurons in the rat's 6-OHDA model of Parkinson's disease.
    Winter C, Hosmann K, Harnack D, Meissner W, Paul G, Morgenstern R, Kupsch A.
    Synapse; 2006 Jul 13; 60(1):69-80. PubMed ID: 16598703
    [Abstract] [Full Text] [Related]

  • 12. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
    Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S.
    J Neurosci Res; 2009 Feb 13; 87(2):576-85. PubMed ID: 18803299
    [Abstract] [Full Text] [Related]

  • 13. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP.
    Neurochem Int; 2006 Jul 13; 49(1):28-40. PubMed ID: 16490285
    [Abstract] [Full Text] [Related]

  • 14. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
    Liu B, Dluzen DE.
    Clin Exp Pharmacol Physiol; 2007 Jul 13; 34(7):555-65. PubMed ID: 17581209
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C, Papazoglou A, Just L, Nikkhah G.
    Exp Cell Res; 2010 Mar 10; 316(5):737-46. PubMed ID: 20060824
    [Abstract] [Full Text] [Related]

  • 16. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY, Lee JE, Park JH, Shin IC, Koh HC.
    Toxicol Lett; 2012 Sep 18; 213(3):332-44. PubMed ID: 22842585
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T.
    Neurochem Int; 2009 Dec 18; 55(8):760-7. PubMed ID: 19647776
    [Abstract] [Full Text] [Related]

  • 18. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G, Bérubé-Carrière N, Mendez JA, Leo D, Riad M, Descarries L, Lévesque D, Trudeau LE.
    Neuroscience; 2008 Sep 22; 156(1):59-70. PubMed ID: 18706980
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
    Iwata SI, Nomoto M, Fukuda T.
    Synapse; 2001 Jan 22; 39(1):16-22. PubMed ID: 11071705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.